본문

  1. Home
461 Results:AA:MA T PP:ELSEVIER INC 0.234 sec.
RSS 
Multilingual
 Расширенный поиск
 Новый поиск книги прибытия
Selected Print Select Export to Excel
331
Parathyroid hormone enhances bone morphogenetic protein activity by increasing intracellular 3′, 5′-cyclic adenosine monophosphate accumulation in osteoblastic MC3T3-E1 cells
Parathyroid hormone enhances bone morphogenetic protein activity by increasing intracellular 3′, 5′-cyclic adenosine monophosphate accumulation in osteoblastic MC3T3-E1 cells
Nakao, Y., | Elsevier Inc | 2009 ,
332
Collagenase expression and activity in the stromal cells from giant cell tumour of bone
Collagenase expression and activity in the stromal cells from giant cell tumour of bone
Cowan, R. W., | Elsevier Inc | 2009 ,
333
Galectin-9 accelerates transforming growth factor β3-induced differentiation of human mesenchymal stem cells to chondrocytes
Galectin-9 accelerates transforming growth factor β3-induced differentiation of human mesenchymal stem cells to chondrocytes
Arikawa, T., | Elsevier Inc | 2009 ,
334
Thrombin-stimulated growth factor and cytokine expression in osteoblasts is mediated by protease-activated receptor-1 and prostanoids
Thrombin-stimulated growth factor and cytokine expression in osteoblasts is mediated by protease-activated receptor-1 and prostanoids
Pagel, C. N., | Elsevier Inc | 2009 ,
335
Osteocyte-derived HB-GAM (pleiotrophin) is associated with bone formation and mechanical loading
Osteocyte-derived HB-GAM (pleiotrophin) is associated with bone formation and mechanical loading
Imai, S., | Elsevier Inc | 2009 ,
336
Prevalence and risk factors of osteoporosis and vertebral fractures in patients with ankylosing spondylitis
Prevalence and risk factors of osteoporosis and vertebral fractures in patients with ankylosing spondylitis
Ghozlani, I., | Elsevier Inc | 2009 ,
337
Bisphosphonate dose and incidence of fractures in postmenopausal osteoporosis
Bisphosphonate dose and incidence of fractures in postmenopausal osteoporosis
Makras, P., | Elsevier Inc | 2009 ,
338
Corrigendum to “Potential use of an estrogen–glucocorticoid receptor chimera as a drug screen for tissue selective estrogenic activity�? [Bone 44 (2009) 102–112]
Corrigendum to “Potential use of an estrogen–glucocorticoid receptor chimera as a drug screen for tissue selective estrogenic activity�? [Bone 44 (2009) 102–112]
Maru, B. S., | Elsevier Inc | 2009 ,
339
EP2 and EP4 receptors differentially mediate MAPK pathways underlying anabolic actions of prostaglandin E2 on bone formation in rat calvaria cell cultures
EP2 and EP4 receptors differentially mediate MAPK pathways underlying anabolic actions of prostaglandin E2 on bone formation in rat calvaria cell cultures
Minamizaki, T., | Elsevier Inc | 2009 ,
340
Proteinase-activated receptor (PAR)-2 activation impacts bone resorptive properties of human osteoarthritic subchondral bone osteoblasts
Proteinase-activated receptor (PAR)-2 activation impacts bone resorptive properties of human osteoarthritic subchondral bone osteoblasts
Amiable, N., | Elsevier Inc | 2009 ,
처음이전29303132333435363738이후마지막